Company intelligence / Profile preview

BetterAge

San Francisco, California, United States

Ownership: Private
Development stage: Other

Overview

BetterAge's web-based AI platform and companion app, developed with NIH support, have demonstrated feasibility and are being validated in broader trials to deliver personalized, evidence-based guidance for healthy aging—particularly for older adults and those supporting individuals with Alzheimer's disease. The platform is active in several states and expanding nationally through pilot and partnership programs[2][4][5].

Therapeutic areas: OtherNeurology
Modalities: Non-pharmacological therapyDigital health platform
Industry: Digital Health Medical Devices

Partnerships

USAging (national association of Area Agencies on Aging and Title VI Native American Aging Programs)More than 40 community-based organizations across the US[2][4]

Beyond the preview

Go deeper on BetterAge.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BetterAge.

Explore the full profile